Redcliffe Labs names Kshitiz Singh as Chief Business Officer

Redcliffe Labs has appointed Kshitiz Singh as Chief Business Officer – Inorganic Growth.

Kshitiz joins Redcliffe Labs with more than 26 years of experience in diagnostics, healthcare, pharmaceuticals, FMCG, sales leadership, business development and commercial strategy.
Before Redcliffe Labs, Kshitiz was General Manager and Business Head at Agilus Diagnostics.

He has earlier held leadership roles at Piramal Enterprises, Abbott India, Heinz India, Sanofi, AstraZeneca, and GlaxoSmithKline.

Aditya Kandoi, Founder & CEO, Redcliffe Labs, said: "The diagnostics industry is entering a phase where scale, integration, and regional reach will define long-term leadership. Across the country, several strong regional diagnostic businesses have built deep clinical expertise and patient trust. We see a significant opportunity to bring these strengths together through an integrated platform that combines technology, clinical excellence, and preventive healthcare. Kshitiz's experience across diagnostics and healthcare will help us accelerate this journey while strengthening our presence across regional markets."

On joining Redcliffe Labs, Kshitiz Singh, Chief Business Officer – Inorganic Growth, said: “India's diagnostics sector presents a significant opportunity to strengthen healthcare through strategic partnerships and capability building. Redcliffe Labs has built a strong foundation for preventive care driven by its commitment and a clear purpose of adding healthy years to lives. I look forward to working with the leadership to identify the growth opportunities, forge strong partnerships, and strengthen our network to bring trusted, high-quality diagnostics to more people across the country."